Boothbay Fund Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $477,961 - $541,855	-35,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $150,138 - $186,959	11,400 Added 47.7%	35,300 $481,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $389,570 - $412,514	23,900 New	23,900 $391,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $175,080 - $234,000	-12,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $156,240 - $243,719	12,000 New	12,000 $182,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.